Shares of Dianthus Therapeutics (DNTH) jumped in the latest session on above‑average trading volume. However, the trend of earnings estimate revisions is deteriorating, which suggests limited further upside for the stock in the near term.
Shares of Dianthus Therapeutics (DNTH) jumped in the latest session on above‑average trading volume. However, the trend of earnings estimate revisions is deteriorating, which suggests limited further upside for the stock in the near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment
